FY2016 EPS Estimates for Natus Medical Inc. Lifted by William Blair (BABY)
Natus Medical Inc. (NASDAQ:BABY) – Equities researchers at William Blair upped their FY2016 EPS estimates for shares of Natus Medical in a note issued to investors on Wednesday. William Blair analyst B. Weinstein now expects that the firm will post earnings per share of $1.73 for the year, up from their prior forecast of $1.69. William Blair also issued estimates for Natus Medical’s FY2017 earnings at $1.88 EPS.
Natus Medical (NASDAQ:BABY) last posted its quarterly earnings data on Wednesday, July 20th. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. During the same period in the prior year, the firm posted $0.34 EPS. The business had revenue of $96 million for the quarter, compared to analyst estimates of $92.71 million. Natus Medical’s revenue for the quarter was up 4.5% on a year-over-year basis.
Separately, Zacks Investment Research raised Natus Medical from a “hold” rating to a “buy” rating and set a $44.00 price objective on the stock in a research note on Thursday, July 7th.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/08/fy2016-eps-estimates-for-natus-medical-inc-lifted-by-william-blair-baby.html
Natus Medical (NASDAQ:BABY) traded up 0.40% during trading on Thursday, hitting $42.89. The company had a trading volume of 200,722 shares. Natus Medical has a one year low of $29.54 and a one year high of $51.05. The stock has a 50-day moving average of $39.16 and a 200-day moving average of $36.29. The stock has a market capitalization of $1.39 billion, a PE ratio of 36.97 and a beta of 0.85.
About Natus Medical
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Natus Medical Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.